Caixampulse will help 20 biomedical projects towards the market

The 4th call of CaixaImpulse programme guides 20 biomedical projects from the laboratory to the market

The development of a diagnostic kit for patients with septicaemia and septic shock, a coating bacterial repellent to reduce hospital-acquired infections and new therapeutic treatments against different types of cancer are examples of some of the 20 biomedical research projects that have been awarded in the 4th edition (2018) of CaixaImpulse.

All the selected projects can be found at the CaixaImpulse website, which have been categorised by different business sectors. Click here to view charts of the categorisation.

In comparison to the previous edition, this year there was a 6% increase in the participation rate, with a total of 85 projects submitted.

After a selection process following the European standards, 20 projects have been chosen to benefit from the programme. Submitted applications came from Spain, Portugal, Italy and Greece.

The three CaixaImpulse projects that will be entirely funded by EIT Health are:

• VReal: Affordable virtual neurological telerehabilitation from Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal;
• NeedleSafe: Antiseptic Biopsy System from Pompeu Fabra University;
• AntiBioCoat from INEB-Instituto Nacional de Engenharia Biomédica.

Since its launch in 2015, CaixaImpulse has allocated €7.5 million to 58 projects. Over this time, more than 400 hours of training have been offered, and more than 300 personal meetings have been held between participants and potential associates or investors. The result is that they have already created ten spin-off projects, with seven more in the pipeline.

For further enquiries contact:

• Alexandre Esteban Franco, aesteban@fundaciolacaixa.org